Report Overview
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
The global Peripheral Arterial Disease (PAD) Therapeutics market size was estimated at USD 2940 million in 2023 and is projected to reach USD 4679.53 million by 2032, exhibiting a CAGR of 5.30% during the forecast period.
North America Peripheral Arterial Disease (PAD) Therapeutics market size was estimated at USD 837.26 million in 2023, at a CAGR of 4.54% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Peripheral Arterial Disease (PAD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Arterial Disease (PAD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Arterial Disease (PAD) Therapeutics market in any manner.
Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co.
Inc. (US)
Proteon Therapeutics
Inc. (US)
Sanofi S.A. (France)
Symic Bio
Inc. (US)
TheraVasc Inc. (US)
AnGes MG
Inc. (Japan)
Athersys
Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics
Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market Segmentation (by Type)
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peripheral Arterial Disease (PAD) Therapeutics Market
Overview of the regional outlook of the Peripheral Arterial Disease (PAD) Therapeutics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peripheral Arterial Disease (PAD) Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Landscape
3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2019-2025)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2019-2025)
3.3 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.6.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peripheral Arterial Disease (PAD) Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peripheral Arterial Disease (PAD) Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2025)
6.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2025)
6.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2019-2025)
7 Peripheral Arterial Disease (PAD) Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2019-2025)
7.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2019-2025)
7.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2025)
8 Peripheral Arterial Disease (PAD) Therapeutics Market Consumption by Region
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Peripheral Arterial Disease (PAD) Therapeutics Market Production by Region
9.1 Global Production of Peripheral Arterial Disease (PAD) Therapeutics by Region (2019-2025)
9.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2019-2025)
9.3 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Peripheral Arterial Disease (PAD) Therapeutics Production
9.4.1 North America Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2019-2025)
9.4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Peripheral Arterial Disease (PAD) Therapeutics Production
9.5.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2019-2025)
9.5.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Peripheral Arterial Disease (PAD) Therapeutics Production (2019-2025)
9.6.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2019-2025)
9.6.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Peripheral Arterial Disease (PAD) Therapeutics Production (2019-2025)
9.7.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Growth Rate (2019-2025)
9.7.2 China Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 AstraZeneca Plc. (UK)
10.1.1 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.1.4 AstraZeneca Plc. (UK) Business Overview
10.1.5 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
10.1.6 AstraZeneca Plc. (UK) Recent Developments
10.2 Bayer HealthCare Pharmaceuticals (Germany)
10.2.1 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
10.2.5 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
10.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
10.3 Bristol-Myers Squibb Company (US)
10.3.1 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
10.3.5 Bristol-Myers Squibb Company (US) Business Overview
10.3.6 Bristol-Myers Squibb Company (US) Recent Developments
10.4 Merck and Co.
10.4.1 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.4.2 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.4.3 Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.4.4 Merck and Co. Business Overview
10.4.5 Merck and Co. Recent Developments
10.5 Inc. (US)
10.5.1 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.5.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.5.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.5.4 Inc. (US) Business Overview
10.5.5 Inc. (US) Recent Developments
10.6 Proteon Therapeutics
10.6.1 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.6.2 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.6.3 Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.6.4 Proteon Therapeutics Business Overview
10.6.5 Proteon Therapeutics Recent Developments
10.7 Inc. (US)
10.7.1 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.7.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.7.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.7.4 Inc. (US) Business Overview
10.7.5 Inc. (US) Recent Developments
10.8 Sanofi S.A. (France)
10.8.1 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.8.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.8.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.8.4 Sanofi S.A. (France) Business Overview
10.8.5 Sanofi S.A. (France) Recent Developments
10.9 Symic Bio
10.9.1 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.9.2 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.9.3 Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.9.4 Symic Bio Business Overview
10.9.5 Symic Bio Recent Developments
10.10 Inc. (US)
10.10.1 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.10.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.10.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.10.4 Inc. (US) Business Overview
10.10.5 Inc. (US) Recent Developments
10.11 TheraVasc Inc. (US)
10.11.1 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.11.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.11.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.11.4 TheraVasc Inc. (US) Business Overview
10.11.5 TheraVasc Inc. (US) Recent Developments
10.12 AnGes MG
10.12.1 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.12.2 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.12.3 AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.12.4 AnGes MG Business Overview
10.12.5 AnGes MG Recent Developments
10.13 Inc. (Japan)
10.13.1 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.13.2 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.13.3 Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.13.4 Inc. (Japan) Business Overview
10.13.5 Inc. (Japan) Recent Developments
10.14 Athersys
10.14.1 Athersys Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.14.2 Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.14.3 Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.14.4 Athersys Business Overview
10.14.5 Athersys Recent Developments
10.15 Inc. (US)
10.15.1 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.15.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.15.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.15.4 Inc. (US) Business Overview
10.15.5 Inc. (US) Recent Developments
10.16 Betagenon AB (Sweden)
10.16.1 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.16.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.16.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.16.4 Betagenon AB (Sweden) Business Overview
10.16.5 Betagenon AB (Sweden) Recent Developments
10.17 miRagen Therapeutics
10.17.1 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.17.2 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.17.3 miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.17.4 miRagen Therapeutics Business Overview
10.17.5 miRagen Therapeutics Recent Developments
10.18 Inc. (US)
10.18.1 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.18.2 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.18.3 Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.18.4 Inc. (US) Business Overview
10.18.5 Inc. (US) Recent Developments
10.19 Multi Gene Vascular Systems Ltd (Israel)
10.19.1 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.19.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.19.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.19.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
10.19.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
10.20 ViroMed Co. Ltd. (Korea)
10.20.1 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
10.20.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
10.20.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
10.20.4 ViroMed Co. Ltd. (Korea) Business Overview
10.20.5 ViroMed Co. Ltd. (Korea) Recent Developments
11 Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region
11.2.4 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Peripheral Arterial Disease (PAD) Therapeutics by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2032)
12.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2032)
12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2022)
Table 10. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Product Type
Table 13. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 23. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 24. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2019-2025)
Table 25. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2025)
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2019-2025)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2019-2025)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2019-2025)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2019-2025) & (K Units)
Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2019-2025)
Table 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2019-2025) & (M USD)
Table 34. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2019-2025)
Table 35. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2025)
Table 36. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2025) & (K Units)
Table 37. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2019-2025)
Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2025) & (K Units)
Table 39. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2025) & (K Units)
Table 41. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2025) & (K Units)
Table 43. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) by Region (2019-2025)
Table 44. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2019-2025)
Table 46. Global Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 52. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 53. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. AstraZeneca Plc. (UK) Business Overview
Table 55. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 56. AstraZeneca Plc. (UK) Recent Developments
Table 57. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 58. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 59. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 61. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 62. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 63. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 64. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 65. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 67. Bristol-Myers Squibb Company (US) Business Overview
Table 68. Bristol-Myers Squibb Company (US) Recent Developments
Table 69. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 70. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 71. Merck and Co. Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Merck and Co. Business Overview
Table 73. Merck and Co. Recent Developments
Table 74. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 75. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 76. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Inc. (US) Business Overview
Table 78. Inc. (US) Recent Developments
Table 79. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 80. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 81. Proteon Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Proteon Therapeutics Business Overview
Table 83. Proteon Therapeutics Recent Developments
Table 84. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 85. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 86. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Inc. (US) Business Overview
Table 88. Inc. (US) Recent Developments
Table 89. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 90. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 91. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Sanofi S.A. (France) Business Overview
Table 93. Sanofi S.A. (France) Recent Developments
Table 94. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 95. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 96. Symic Bio Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Symic Bio Business Overview
Table 98. Symic Bio Recent Developments
Table 99. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 100. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 101. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Inc. (US) Business Overview
Table 103. Inc. (US) Recent Developments
Table 104. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 105. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 106. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. TheraVasc Inc. (US) Business Overview
Table 108. TheraVasc Inc. (US) Recent Developments
Table 109. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 110. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 111. AnGes MG Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. AnGes MG Business Overview
Table 113. AnGes MG Recent Developments
Table 114. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 115. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 116. Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Inc. (Japan) Business Overview
Table 118. Inc. (Japan) Recent Developments
Table 119. Athersys Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 120. Athersys Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 121. Athersys Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Athersys Business Overview
Table 123. Athersys Recent Developments
Table 124. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 125. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 126. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Inc. (US) Business Overview
Table 128. Inc. (US) Recent Developments
Table 129. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 130. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 131. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Betagenon AB (Sweden) Business Overview
Table 133. Betagenon AB (Sweden) Recent Developments
Table 134. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 135. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 136. miRagen Therapeutics Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. miRagen Therapeutics Business Overview
Table 138. miRagen Therapeutics Recent Developments
Table 139. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 140. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 141. Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. Inc. (US) Business Overview
Table 143. Inc. (US) Recent Developments
Table 144. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 145. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 146. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 148. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 149. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 150. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 151. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. ViroMed Co. Ltd. (Korea) Business Overview
Table 153. ViroMed Co. Ltd. (Korea) Recent Developments
Table 154. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 155. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 157. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 159. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 161. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 163. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Type (2025-2032) & (K Units)
Table 167. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Peripheral Arterial Disease (PAD) Therapeutics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 169. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application (2025-2032)
Table 170. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2019-2025)
Figure 19. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2023
Figure 20. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2019-2025)
Figure 21. Market Size Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 24. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2019-2025)
Figure 25. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2019-2025)
Figure 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2023
Figure 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2025)
Figure 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2019-2025)
Figure 30. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Peripheral Arterial Disease (PAD) Therapeutics Production Market Share by Region (2019-2025)
Figure 62. North America Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 65. China Peripheral Arterial Disease (PAD) Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Application (2025-2032)
